Free Trial
OTCMKTS:ECIA

Encision (ECIA) Stock Price, News & Analysis

$0.42 0.00 (0.00%)
As of 04/25/2025

About Encision Stock (OTCMKTS:ECIA)

Key Stats

Today's Range
$0.42
$0.42
50-Day Range
$0.38
$0.49
52-Week Range
$0.12
$0.57
Volume
N/A
Average Volume
5,249 shs
Market Capitalization
$4.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

Receive ECIA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encision and its competitors with MarketBeat's FREE daily newsletter.

ECIA Stock News Headlines

Trump’s Secret Social Security Plan?
In less than a decade, Social Security could be out of money. But a surprising plan from Trump’s inner circle may not just save the system — it could unlock a major opportunity for savvy investors. Financial insider Jim Rickards calls it “Social Prosperity,” and says those who act now could see the biggest gains.
Encision Inc (ECIA)
Encision Reports Third Quarter Fiscal Year 2024 Results
See More Headlines

ECIA Stock Analysis - Frequently Asked Questions

Encision's stock was trading at $0.45 at the beginning of 2025. Since then, ECIA stock has decreased by 6.7% and is now trading at $0.42.
View the best growth stocks for 2025 here
.

Encision Inc. (OTCMKTS:ECIA) issued its earnings results on Thursday, May, 14th. The medical device company reported ($0.01) earnings per share for the quarter. The medical device company had revenue of $1.78 million for the quarter. Encision had a negative trailing twelve-month return on equity of 32.90% and a negative net margin of 8.96%.

Shares of ECIA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Encision investors own include Akers Biosciences (AKER), MGT Capital Investments (MGTI), Brainstorm Cell Therapeutics (BCLI), Aviat Networks (AVNW), Activision Blizzard (ATVI), ATI (ATI) and Digital Turbine (APPS).

Company Calendar

Last Earnings
5/14/2020
Today
4/26/2025
Next Earnings (Estimated)
7/14/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:ECIA
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-690,000.00
Pretax Margin
-7.85%

Debt

Sales & Book Value

Annual Sales
$6.59 million
Price / Cash Flow
N/A
Book Value
$0.14 per share
Price / Book
3.00

Miscellaneous

Free Float
7,514,000
Market Cap
$4.99 million
Optionable
Not Optionable
Beta
0.61
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:ECIA) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners